NIH pre-clinical screening program: overview and current status.

NIH pre-clinical screening program: overview and current status.

Item
http://www.wikidata.org/entity/Q36027521
Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivoEnhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosisDetection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MSMemory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) populationThe fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophagesAssessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.The importance of animal models in tuberculosis vaccine development.Epidemiologic consequences of microvariation in Mycobacterium tuberculosis.Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity.Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model.Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.Mycobacterial infection induces the secretion of high-mobility group box 1 protein.Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells.
P2860

NIH pre-clinical screening program: overview and current status.

Item
http://www.wikidata.org/entity/Q36027521
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
NIH pre-clinical screening program: overview and current status.
@ast
NIH pre-clinical screening program: overview and current status.
@en
type
label
NIH pre-clinical screening program: overview and current status.
@ast
NIH pre-clinical screening program: overview and current status.
@en
prefLabel
NIH pre-clinical screening program: overview and current status.
@ast
NIH pre-clinical screening program: overview and current status.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
NIH pre-clinical screening program: overview and current status.
@en
P2093
P304
P31
P356
10.1016/J.TUBE.2004.09.008
P433
P478
P577
P698